Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News CervoMed Inc CRVO

Healthcare Biotechnology
CervoMed Inc., a a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule brain penetrant that inhibits p38 mitogen-activated protein kinase alpha. Neflamapimod has the potential to treat synaptic dysfunction, the reversible aspect of... see more

Current News (NDAQ:CRVO)

CervoMed Announces Late-Breaking Data at the 18th CTAD Conference Demonstrating Neflamapimod Significantly Slows Clinical Progression in Dementia with Lewy Bodies

GlobeNewswire December 4, 2025

CervoMed Presents New Plasma Biomarker Data That Indicates Neflamapimod Broadly Improves Neuroinflammation and Neurodegeneration in Dementia with Lewy Bodies (DLB)

GlobeNewswire December 2, 2025

CervoMed to Share New Data on Neflamapimod as a Treatment for Dementia with Lewy Bodies at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference

GlobeNewswire November 24, 2025

CervoMed Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

GlobeNewswire November 10, 2025

CervoMed Announces Alignment with FDA on Registration Path for Neflamapimod in Dementia with Lewy Bodies

GlobeNewswire November 4, 2025

CervoMed Strengthens Board with Appointment of Life Sciences Business Strategy Leader David Quigley

GlobeNewswire October 28, 2025

CervoMed to Present at the Emerging Growth Conference

GlobeNewswire October 20, 2025

CervoMed Announces New Data from Phase 2b Trial Demonstrating Neflamapimod's Potential as a Treatment for Dementia with Lewy Bodies

GlobeNewswire October 8, 2025

CervoMed Appoints Matthew Winton, Ph.D., as Chief Commercial and Business Officer

GlobeNewswire October 7, 2025
View More News ››

Opinion & Analysis (NDAQ:CRVO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CRVO)

Using technical analysis for this stock.

It is signalling a continuing uptrend for shareholders today anyway so good luck to all
coolfooldumbguy - July 28, 2025

Buy buddy buy.

Otherwise you guys out there will be left behind by this one,so good to all shareholders
coolfooldumbguy - June 24, 2025

Buy buddy buy because it's taking off this morning.

Otherwise you guys out there will be left behind by the markets and 
coolfooldumbguy - March 18, 2025

Using technical analysis for this one.

This stock will keep climbing steadily upward this morning,so good luck to all
coolfooldumbguy - March 13, 2025

Upgraded target price helps

Bought in this morning already looking at a double! love these volume plays
Tradinghands - March 12, 2025
View more Bullboard ››

Alvopetro Energy Ltd.

Alvopetro Energy Ltd.

Alvopetro Energy Ltd. engages in the acquisition, exploration, development, and production of hydrocarbons in Brazil and ...
View More »

Podcasts